- Nachrichtendetail
-
06.03.2024 15:07:00 - dpa-AFX: *J&J SEEKS EMA APPROVAL FOR DARZALEX QUADRUPLET THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
JOHNSON + JOHNSON DL 1 | 853260 | Frankfurt | 139,760 | 14.05.24 17:20:00 | +0,200 | +0,14% | 139,380 | 139,720 | 140,760 | 139,560 |
